Chris Pasquale

Stock Analyst at Guggenheim

(0.40)
# 4,187
Out of 5,067 analysts
3
Total ratings
n/a
Success rate
-9.93%
Average return

Stocks Rated by Chris Pasquale

DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $62.21
Upside: +133.08%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $76.01
Upside: +62.81%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $45
Current: $30.01
Upside: +49.95%